Disparities in antidepressant adherence in primary care: Report from Israel

American Journal of Managed Care

Volumn 17, Issue 9, 2011, Pages

  Ayalon, Liat ^a   Gross, Revital ^a   Yaari, Aviv ^b   Feldhamer, Elan ^b   Balicer, Ran D ^b,c   Goldfracht, Margalit ^b,d  

^a BAR ILAN UNIVERSITY   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DEPRESSION; GENERAL PRACTITIONER; HEALTH CARE DISPARITY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MANAGED CARE; MENTAL HEALTH CARE; MENTAL PATIENT; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SOCIAL STATUS;

ANTIDEPRESSIVE AGENTS; FEMALE; HEALTH CARE SURVEYS; HEALTH STATUS DISPARITIES; HEALTH STATUS INDICATORS; HUMANS; ISRAEL; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; REGISTRIES; SOCIAL CLASS; STATISTICS AS TOPIC; UNIVERSAL COVERAGE;

EID: 80052975858     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152(3):352-357.
2. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression [published correction appears in JAMA. 2003;290(16):2218]. JAMA. 2003;289(23): 3135-3144. (Pubitemid 37432889)
3. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF. Depression and mortality in nursing homes. JAMA.1991;265(8):993-996.
4. Carta MG, Hardoy MC, Kovess V, Dell'Osso L, Carpiniello B. Could health care costs for depression be decreased if the disorder were correctly diagnosed and treated? Soc Psychiatry Psychiatr Epidemiol. 2003;38(9):490-492.
5. Tabenkin H, Gross R, Yaphe Y. The general practitioner as physician of first contact with health problems [in Hebrew]. Harefuah. 1995; 129(9):297-303, 368.
6. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-325. (Pubitemid 351650592)
7. Ornstein S, Stuart G, Jenkins R. Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet). J Fam Pract. 2000;49(1):68-72. (Pubitemid 30489238)
8. Wittchen HU, Kessler RC, Beesdo K, Krause P, Höfler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(suppl 8):24-34. (Pubitemid 34535254)
9. Arroll B, Macgillivray S, Ogston S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3(5):449-456. (Pubitemid 41512663)
10. Davidson JR, Feltner DE, Dugar A. Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. Prim Care Companion J Clin Psychiatry. 2010;12(2).
11. Tabenkin H, Monitz H, Goldfracht M, Peled O. Clinical guidelines for the diagnosis and treatment of depression in the community. Clalit Health Services (in Hebrew). 2006.
12. Bower P, Gilbody S. Managing common mental health disorders in primary care: conceptual models and evidence base. BMJ. 2005; 330(7495):839-842. (Pubitemid 40529808)
13. Chen SY, Hansen RA, Gaynes BN, Farley JF, Morrissey JP, Maciejewski ML. Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry. 2010;32(4):360-367.
14. Davidson JR, Zhang W, Connor KM, et al. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol. 2010;24(1):3-26.
15. Fairman KA, Drevets WC, Kreisman JJ, Teitelbaum F. Course of antidepressant treatment drug type, and prescriber's specialty. Psychiatr Serv. 1998;49(9):1180-1186. (Pubitemid 28414682)
16. Bull SA, Hunkeler EM, Lee JY, et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother. 2002;36(4):578-584. (Pubitemid 34270268)
17. Hansen DG, Vach W, Rosholm JU, Søndergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract. 2004;21(6):623-629. (Pubitemid 39654859)
18. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163(1):101-108. (Pubitemid 43050110)
19. Akerblad AC, Bengtsson F, Holgersson M, von Knorring L, Ekselius L. Identification of primary care patients at risk of nonadherence to antidepressant treatment. Patient Prefer Adherence. 2008;2:379-386.
20. Sayuk GS, Elwing JE, Lustman PJ, Clouse RE. Predictors of premature antidepressant discontinuation in functional gastrointestinal disorders. Psychosom Med. 2007;69(2):173-181. (Pubitemid 46667985)
21. Stein MB, Cantrell CR, Sokol MC, Eaddy MT, Shah MB. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatr Serv. 2006;57(5):673-680.
22. Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication [published correction appears in Ann Fam Med. 2005;3(6):558]. Ann Fam Med. 2005;3(1):23-30. (Pubitemid 40203944)
23. Brown C, Battista DR, Bruehlman R, Sereika SS, Thase ME, Dunbar- Jacob J. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care. 2005; 43(12):1203-1207. (Pubitemid 43012177)
24. Ayalon L, Areán PA, Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am J Geriatr Psychiatry. 2005;13(7):572-580.
25. Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91-99. (Pubitemid 46607462)
26. McCann TV, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J Psychiatr Ment Health Nurs. 2008;15(8):622-629.
27. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry. 1997;170:120-127. (Pubitemid 27120644)
28. McCann DP, Blossom HJ. The physician as a patient educator: from theory to practice. West J Med. 1990;153(1):44-49. (Pubitemid 20221834)
29. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15(6): 399-408. (Pubitemid 24006273)
30. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33(1):67-74.
31. Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ. Effect of mental health specialty care on antidepressant length of therapy. Med Care. 1999;37(4)(suppl Lilly):AS20-AS23.
32. Brook OH, van Hout H, Stalman W, et al. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr Serv. 2005;56(4):487-489. (Pubitemid 40471595)
33. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289(23):3145-3151. (Pubitemid 37432890)
34. Wang PS, Patrick AR, Dormuth CR, et al. The impact of cost sharing on antidepressant use among older adults in British Columbia. Psychiatr Serv. 2008;59(4):377-383.
35. Shirom A, Gross R. World health systems: Israel. In: Fried BJ, Gaydos LM, eds. World Health Systems: Challenges and Perspectives. Ann Arbor, MI: Health Administration Press; 2002:207-225.
36. Sallis JF, Saelens BE. Assessment of physical activity by self-report: status, limitations, and future directions [published correction appears in Res Q Exerc Sport. 2000;71(4):409]. Res Q Exerc Sport. 2000;71(2) (suppl):S1-S14.
37. Rabinowitz J, Feldman D, Gross R, Boerma W. Which primary care physicians treat depression? Psychiatr Serv. 1998;49(1):100-102.
38. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
39. Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004;4:94.
40. Clauw DJ. Pharmacotherapy for patients with fibromyalgia. J Clin Psychiatry. 2008;69(suppl 2):25-29.
41. Pary R, Tobias CR, Webb WK, Lippmann SB. Treatment of insomnia: getting to the root of sleeping problems. Postgrad Med. 1996;100(5):195-198, 201-210.
42. Finocchi C, Villani V, Casucci G. Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci. 2010;31(suppl 1):S95-S98.
43. Teasell RW, Mehta S, Aubut JA, et al; Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil. 2010;91(5):816-831.
44. Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician. 2010;82(2):151-158.
45. Goldfracht M, Liebermann N, Gross R. Treating mental distress by primary care staff. Health Policy Monitor, October 2006. Available at http://www.hpm.org/survey/is/a8/3.
46. Central Bureau of Statistics. Classification of Municipalities by the Socio-economic Characteristics of the Population. Jerusalem, Israel: Central Bureau of Statistics; 2003.
47. Gross R, Brammli-Greenberg S, Gordon B, Rabinowitz J, Afek A. Disparities in obesity temporal trends of Israeli adolescents by ethnic origin Int J Pediatr Obes. 2011;6(2-2):e154-e161.
48. Gross R, Brammli-Greenberg S, Gordon B, Rabinowitz J, Afek A. Population-based trends in male adolescent obesity in Israel 1967- 2003. J Adolesc Health. 2009;44(2):195-198.
49. Falah G. Living together apart: residential segregation in mixed Arab-Jewish cities in Israel. Urban Stud. 1996;33(6):823-857.
50. Hox J. Multilevel Analysis: Techniques and Application. Mahwah, NJ: Lawrence Erlbaum; 2002.
51. Snijders T, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage; 1999.
52. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995;310(6992):1433-1438.
53. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review [published online ahead of print March 17, 2011. J Clin Pharmacol. 2011.